New PET scan hunts down hidden prostate cancer for precision radiation
NCT ID NCT03160794
First seen Jun 22, 2026 · Last updated Jun 22, 2026
Summary
This study tested a new type of PET/MRI scan that uses a special tracer to find small spots of prostate cancer that standard scans miss. Men with a rising PSA after prostate surgery and radiation received targeted radiation to those spots. The goal was to see if this approach can detect and treat early cancer spread, potentially controlling the disease without immediate hormone therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST PROSTATECTOMY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F]DCFPyL (a radioactive tracer for PET scans) and stereotactic ablative radiotherapy (SABR)
What this could lead to
If successful, this approach could allow earlier detection and targeted treatment of prostate cancer that has spread, potentially delaying the need for hormone therapy and improving disease control.
What could go wrong
This is a Phase 2 study with 150 participants, so results are preliminary. The imaging may not find all cancer spots, and radiation could miss some targets or cause side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.